Kinetic Modelling of Drug Release from Pentoxifylline Matrix Tablets based on Hydrophilic, Lipophilic and Inert Polymers

Open access


Pentoxifylline is a xanthine derivative used in the treatment of peripheral vascular disease, which because of its pharmacokinetic and pharmacologic profile is an ideal candidate for the development of extended release formulations. The aim of this study is to present a kinetic analysis of the pentoxifylline release from different extended release tablets formulations, using mechanistic and empirical kinetic models. A number of 28 formulations were prepared and analysed; the analysed formulations differed in the nature of the matrix forming polymers (hydrophilic, lipophilic, inert) and in their concentrations. Measurements were conducted in comparison with the reference product Trental 400 mg (Aventis Pharma). The conditions for the dissolution study were according to official regulations of USP 36: apparatus no. 2, dissolution medium water, volume of dissolution medium is 1,000 mL, rotation speed is 50 rpm, spectrophotometric assay at 274 nm. Six mathematical models, five mechanistic (0 orders, 1st-order release, Higuchi, Hopfenberg, Hixson-Crowell) and one empirical (Peppas), were fitted to pentoxifylline dissolution profile from each pharmaceutical formulation. The representative model describing the kinetics of pentoxifylline release was the 1st-order release, and its characteristic parameters were calculated and analysed.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Costa P Lobo JMS. Modelling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123-133.

  • [2] Kohler AN Murphree ES. A comparison of the Akaike and Schwarz criteria for selecting model order. Appl Statist. 1998;37:187-195.

  • [3] Ludden TM Beal SL Sheiner LB. Comparison of the Akaike Information Criterion the Schwarz criterion and the F test as guides to model selection. J. Pharmacokinetic Biopharm. 1994;22:431-445.

  • [4] Martindale The Complete Drug Reference. 37th ed. London Pharmaceutical Press; 2011 1367p.

  • [5] Ramteke KH Dighe PA Kharat AR Patil SV. Mathematical models of drug dissolution: a review. Sch. Acad. J. Pharm. 2014;3:388-396.

  • [6] Sathe PM Tsong Y Shah VP. In-vitro dissolution profile comparison: statistics and analysis model dependent approach. Pharm Res. 1996;13:1799-1803.

  • [7] The United States Pharmacopeia. 36th ed. Rockwell: United States Pharmacopeial Convention 2014.

  • [8] van Vooren L Krikilion G Rosier J de Spiegelee B. A novel bending point criterion for dissolution profile interpretation. Drug Dev Ind Pharm. 2001;27:885-892.

  • [9] Ward A Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs 1987;34:50-97.

Journal information
Impact Factor

CiteScore 2018: 0.39

SCImago Journal Rank (SJR) 2018: 0.128
Source Normalized Impact per Paper (SNIP) 2018: 0.337

Cited By
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 386 263 16
PDF Downloads 210 161 5